Plasma DCLK1 is a marker of hepatocellular carcinoma (HCC): Targeting DCLK1 prevents HCC tumor xenograft growth via a microRNA-dependent mechanism.
Sureban SM, Madhoun MF, May R, Qu D, Ali N, Fazili J, Weygant N, Chandrakesan P, Ding K, Lightfoot SA, Houchen CW. Plasma DCLK1 is a marker of hepatocellular carcinoma (HCC): Targeting DCLK1 prevents HCC tumor xenograft growth via a microRNA-dependent mechanism. Oncotarget. 2015 Nov 10; 6(35):37200-15.
-
Animals
-
Animals
-
Biomarkers, Tumor
-
Biomarkers, Tumor
-
Carcinoma, Hepatocellular
-
Carcinoma, Hepatocellular
-
Cell Line, Tumor
-
Cell Line, Tumor
-
Cell Proliferation
-
Cell Proliferation
-
Databases, Genetic
-
Databases, Genetic
-
Gene Expression Regulation, Neoplastic
-
Gene Expression Regulation, Neoplastic
-
Gene Knockdown Techniques
-
Gene Knockdown Techniques
-
Genetic Therapy
-
Genetic Therapy
-
Humans
-
Humans
-
Intracellular Signaling Peptides and Proteins
-
Intracellular Signaling Peptides and Proteins
-
Liver Cirrhosis
-
Liver Cirrhosis
-
Liver Neoplasms
-
Liver Neoplasms
-
Mice, Nude
-
Mice, Nude
-
MicroRNAs
-
MicroRNAs
-
Neoplastic Stem Cells
-
Neoplastic Stem Cells
-
Phenotype
-
Phenotype
-
Retrospective Studies
-
Retrospective Studies
-
RNA Interference
-
RNA Interference
-
RNAi Therapeutics
-
RNAi Therapeutics
-
Signal Transduction
-
Signal Transduction
-
Time Factors
-
Time Factors
-
Transcription Factors
-
Transcription Factors
-
Transfection
-
Transfection
-
Tumor Burden
-
Tumor Burden
-
Up-Regulation
-
Up-Regulation
-
Xenograft Model Antitumor Assays
-
Xenograft Model Antitumor Assays